关注
Almudena Bosch
Almudena Bosch
在 mssm.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
NR2F1 controls tumour cell dormancy via SOX9-and RARβ-driven quiescence programmes
MS Sosa, F Parikh, AG Maia, Y Estrada, A Bosch, P Bragado, E Ekpin, ...
Nature communications 6 (1), 6170, 2015
3012015
Cbx8 acts non-canonically with Wdr5 to promote mammary tumorigenesis
CY Chung, Z Sun, G Mullokandov, A Bosch, ZA Qadeer, E Cihan, Z Rapp, ...
Cell reports 16 (2), 472-486, 2016
1052016
The epigenetic regulators Bmi1 and Ring1B are differentially regulated in pancreatitis and pancreatic ductal adenocarcinoma
C Martínez‐Romero, I Rooman, A Skoudy, C Guerra, X Molero, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009
662009
Reversal by RARα agonist Am580 of c-Myc-induced imbalance in RARα/RARγ expression during MMTV-Myc tumorigenesis
A Bosch, SP Bertran, Y Lu, A Garcia, AM Jones, MI Dawson, EF Farias
Breast cancer research 14, 1-19, 2012
492012
The Polycomb group protein RING1B is overexpressed in ductal breast carcinoma and is required to sustain FAK steady state levels in breast cancer epithelial cells
A Bosch, K Panoutsopoulou, JM Corominas, R Gimeno, G Moreno-Bueno, ...
Oncotarget 5 (8), 2065, 2014
392014
CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer
M Ahmed, F Soares, JH Xia, Y Yang, J Li, H Guo, P Su, Y Tian, HJ Lee, ...
Nature communications 12 (1), 1781, 2021
382021
Histone H3 lysine 27 crotonylation mediates gene transcriptional repression in chromatin
N Liu, T Konuma, R Sharma, D Wang, N Zhao, L Cao, Y Ju, D Liu, ...
Molecular Cell 83 (13), 2206-2221. e11, 2023
132023
Blocking the PAH2 domain of Sin3A inhibits tumorigenesis and confers retinoid sensitivity in triple negative breast cancer
N Bansal, A Bosch, B Leibovitch, L Pereira, E Cubedo, J Yu, ...
Oncotarget 7 (28), 43689, 2016
112016
NR2F1 controls tumour cell dormancy via SOX9-and RARbeta-driven quiescence programmes. Nat Commun 6: 6170
MS Sosa, F Parikh, AG Maia, Y Estrada, A Bosch, P Bragado, E Ekpin, ...
Acknowledgment, 2015
82015
NR2F1 controls tumour cell dormancy via SOX9-and RARβ-driven quiescence programmes. Nat Commun. 2015; 6: 6170
MS Sosa, F Parikh, AG Maia, Y Estrada, A Bosch, P Bragado, E Ekpin, ...
7
Dysfunction of ubiquitin protein ligase MYCBP2 leads to cell resilience in human breast cancers
RA Neff, A Bosch-Gutierrez, Y Sun, I Katsyv, W Song, M Wang, MJ Walsh, ...
NAR cancer 5 (3), zcad036, 2023
12023
Targeted epigenetic reprogramming reverts tumor progression in triple-negative breast cancer models by the activation of retinoic acid receptor alpha
N Bansal, A Bosch, BA Leibovitch, K Pierzchalski, Z Ming-Ming, M Kane, ...
Cancer Research 75 (15_Supplement), 3511-3511, 2015
2015
NR2F1 controls tumor cell fate via SOX9 and RAR beta driven quiescence and pluripotency programs
MS Sosa, Y Estrada, F Parikh, A Bosch, Y Zheng, P Bragado, E Ekpin, ...
CLINICAL & EXPERIMENTAL METASTASIS 32 (3), 240-240, 2015
2015
Abstract A021: Loss-of-function screen for breast tumor initiating cells reveals PRC1 dependence
CY Chung, A Gaspar-Maia, G Mullokandov, A Bosch-Gutierrez, E Farias, ...
Molecular Cancer Research 11 (10_Supplement), A021-A021, 2013
2013
NR2F1 coordinates a dormancy program by inducing low self-renewal capacity and a repressive chromatin state.
MS Sosa, Y Estrada, F Parikh, AB Gutierrez, Y Zheng, P Bragado, E Ekpin, ...
Cancer Research 73 (8_Supplement), 1090-1090, 2013
2013
NR2F1 and SOX9 mediate reprogramming of tumor cells into dormancy: Potential role in dormant bone marrow DTCs
MS Sosa, Y Estrada, F Parikh, A Bosch-Gutierrez, E Ekpin, A George, ...
Cancer Research 72 (8_Supplement), 4262-4262, 2012
2012
Role of Ring1B in ephitelial to mesenchimal transition, invasion and migration of mammary epithelial cells
A Bosch Gutiérrez
Universitat Pompeu Fabra, 2009
2009
Un caso inusual de carcinoma ductal invasor desarrollado sobre un tumor phyllodes maligno
AL Bosch
系统目前无法执行此操作,请稍后再试。
文章 1–18